Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?0

• SCIENCE, Science / Health, Science Mission Directorate, scientists, Space, Space Communications & Navigation Program, Space Launch System (SLS), Space Telescope, space-x-ipo, SpaceX
• August 20, 2026

A cancer vaccine developed by Moderna and Merck reduced the recurrence of melanoma.Credit: Adam Glanzman/Bloomberg/Getty A personalized mRNA vaccine for melanoma reduced the risk of the cancer returning in a phase III clinical trial, the companies behind the trial announced this week. The vaccine — which relies on the same mRNA technology used to develop